SCHEMBL8325433

SCHEMBL8325433

COc1ccc(C(=O)N(C)C)cc1F

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.67
LMNA P02545 1/20 0.67
MAPK1 P28482 1/20 0.67
RAB9A P51151 1/20 0.67
ACHE P22303 1/20 0.53
TAS1R3 Q7RTX0 1/20 0.50
TAS1R1 Q7RTX1 1/20 0.50
ALDH1A1 P00352 3/20 0.47
MEN1 O00255 1/20 0.47
MAPT P10636 1/20 0.47
KMT2A Q03164 1/20 0.47
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46
KCNQ3 O43525 1/20 0.46
KCNQ2 O43526 1/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
HPGD P15428 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29797355 0.87 HTT (0.63) HTTLMNAMAPK1RAB9AACHE
SCHEMBL4822355 0.87 HTT (0.63) HTTLMNAMAPK1RAB9AACHE
SCHEMBL6409033 0.84 CYP2C9 (0.66) LMNAMAPK1ALDH1A1MAPTKMT2A
SCHEMBL16908264 0.83 RAB9A (0.47) HTTLMNAMAPK1RAB9AACHE
SCHEMBL24476677 0.82 HSP90AA1 (0.66) HTTLMNAMAPK1RAB9AACHE
SCHEMBL28217099 0.82 HTT (0.76) HTTLMNAMAPK1RAB9AACHE
SCHEMBL8324485 0.82 HTT (0.56) HTTLMNAMAPK1RAB9AACHE
SCHEMBL12062763 0.81 TAS1R3 (0.49) TAS1R3TAS1R1ALDH1A1MEN1KMT2A
SCHEMBL503994 0.80 HTT (1.00) HTTLMNAMAPK1RAB9AACHE
SCHEMBL313217 0.80 LMNA (0.73) HTTLMNAMAPK1RAB9AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1592426-B1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2007-12-19 EP disclosed
WO-2004069256-A1 2-CYANOPYRROLOPYRIMIDINES AND PHARMACEUTICAL USES THEREOF NOVARTIS AG (CH) 2004-08-19 WO disclosed